BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38711471)

  • 1. Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis.
    Wang M; Hao M; Cui X; Liu M; Zhang C; Wang S
    Int J Antimicrob Agents; 2024 Jun; 64(2):107237. PubMed ID: 38851461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of short- versus prolonged-courses of antimicrobial therapy for carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A propensity score-matched cohort study.
    You TY; Lo CL; Tsai WC; Jan HE; Ko WC; Lee NY
    J Microbiol Immunol Infect; 2024 May; ():. PubMed ID: 38849216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales.
    Saidel-Odes L; Sagi O; Troib S; Leeman H; Nativ R; Schlaeffer-Yosef T; Azulay H; Nesher L; Borer A
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-Resistant NDM and OXA-48-
    Lazar DS; Nica M; Dascalu A; Oprisan C; Albu O; Codreanu DR; Kosa AG; Popescu CP; Florescu SA
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, antimicrobial resistance and mortality of
    Xiao S; Zhou S; Cao H; Han L; Zhao S; Wang X
    Infect Dis (Lond); 2024 Jul; ():1-10. PubMed ID: 38963702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Predictors of Bacteremia Outcome After Initial Empirical Antimicrobial Therapy in Patients with Hematological Malignancies: A Retrospective Analysis.
    Gao J; Zheng J; Zhang H; Wang J; Jing H
    Infect Drug Resist; 2024; 17():2099-2107. PubMed ID: 38828373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Molecular Characteristics of Patients with Bloodstream Infections Caused by KPC and NDM Co-Producing Carbapenem-Resistant
    Li J; Wu W; Wu M; Zhou Z; Wang J; Qiu M; Xu L; Ren J; Wu X
    Infect Drug Resist; 2024; 17():1685-1697. PubMed ID: 38711471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant
    Zhou Y; Wu X; Wu C; Zhou P; Yang Y; Wang B; Xu Y; Zhao H; Guo Y; Yu J; Yu F
    mSphere; 2024 Jan; 9(1):e0061223. PubMed ID: 38193656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
    Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
    Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Resistance Patterns, Sequence Types, Virulence and Carbapenemase Genes of Carbapenem-Resistant
    Shen M; Chen X; He J; Xiong L; Tian R; Yang G; Zha H; Wu K
    Infect Drug Resist; 2023; 16():637-649. PubMed ID: 36743338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbapenemase Genes, Virulence Genes, and Molecular Epidemiology of Carbapenem-Resistant
    Liao Q; Yuan Y; Zhang W; Deng J; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):391-396. PubMed ID: 38645859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed
    Gupta N; Boodman C; Prayag P; Manesh A; Kumar TP
    Expert Rev Anti Infect Ther; 2024 Apr; 22(4):203-209. PubMed ID: 38258529
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.